Abbott beats quarterly profit estimates on demand for medical devices
(Reuters) -Abbott Laboratories on Thursday reported second-quarter profit above expectations, due to recovery in surgical procedure volumes and demand for its diabetes care devices.
Demand for medical devices is expected to rise this year, tracking a recovery in non-urgent surgical procedures across the U.S., as... Read More.